New Perspectives provides support and leadership for emerging biotechnology and pharmaceutical companies by helping to maximize your developmental assets in the commercial setting. We help companies build a take-to-market strategy, obtain investment, or package an asset for licensure or sale. Our experience encompasses NCE, 505b2, orphan drugs, BPLA, generics, devices and biosimilars. Whether you are developing your product for licensing or planning on commercializing it yourself, we’re focused on its success. Our team partners with your team to establish your product’s value proposition, differentiate it from the competition and shape your product’s ultimate strategic direction for launch and commercial success. We’ve been bringing new perspectives to life science commercialization since 2008. Over their careers and as consultants, our team has collectively launched 42 products in 32 therapeutic areas, delivering over $20 billion in annual peak revenue. We’re industry veterans. We’ve worked-in and advised pharmaceutical companies both large and small, launched fledgling biotech organizations’ first successful products, and nurtured companies from Pre-IND all the way to FDA approval. Each of these hundreds of experiences has added invaluable perspective to our work while leaving our enthusiasm intact. For us, it is about giving clients an edge and patients a solution. We do this not by using templates as answers, but by analyzing your asset in light of the competitive environment and providing strategic solutions to address your unique business needs. External Objectivity Internal Accountability Contact us: +1-919-641-8146